Aleniglipron
ACCESS II
Gasherbrum Bio, Inc · Phase 2 · Completed · Enrollment 85
| Arm | Population | Dose | Weeks | Estimand | Weight change |
|---|---|---|---|---|---|
| Sentinel | Obesity or overweight | n/r | n/r | n/r | n/r |
| Cohort 1a | Obesity or overweight | n/r | n/r | n/r | n/r |
| Cohort 1b | Obesity or overweight | n/r | n/r | n/r | n/r |
| Cohort 1c | Obesity or overweight | n/r | n/r | n/r | n/r |